CBD Is Out of the Block—Will Regulators Catch Up?
According to the Council for Responsible Nutrition, the market for hemp-derived food, supplements and personal care products containing CBD has exploded—surpassing $190 million. And it is expected to skyrocket to beyond $650 million in another five years.
However, the Food and Drug Administration has recently reminded stakeholders that it remains technically unlawful to market CBD as an ingredient because CBD is an active ingredient in an FDA-approved drug and was the subject of substantial clinical investigations prior to being marketed in foods or supplements. At the same time, the agency has noted that there are pathways available for those who seek to lawfully introduce hemp extracts with CBD into interstate commerce.
But these pathways must be lit by science—and the publicly available research on the many variations of hemp-derived CBD products reveals that the science behind this compound is still emerging.
Join this session to learn more about the science behind CBD and its role in regulatory compliance and market growth.